Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07336537 · ClinicalTrials.gov registry record · NA

Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software

A NA study of Chronic Pain and Mental Health Disorders, sponsored by AugMend Health.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT07336537: Recruiting NA study of Chronic Pain and Mental Health Disorders, sponsored by AugMend Health.

NCT07336537 is a NA study of Chronic Pain and Mental Health Disorders that is actively recruiting participants, run by AugMend Health. The registered enrollment target is 100 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07336537, a NA study of Chronic Pain and Mental Health Disorders, is actively recruiting participants, sponsored by AugMend Health.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This research study is being conducted to evaluate digital software tools that collect health information through conversations. The study will test how acceptable, feasible, and usable these conversational software programs are for patients with chronic pain. Purpose of the Study: The goal is to understand whether digital conversational tools can effectively gather biopsychosocial information (biological, psychological, and social factors related to health) from patients experiencing chronic pain. Biopsychosocial information includes details about your physical symptoms, emotional well-being, social circumstances, and how these factors interact to affect your health. These digital tools are designed to have conversation-like interactions with patients to collect this comprehensive health data in a more natural and engaging way. What Participation Involves: If you join this study, you will interact with digital conversational software that will ask you questions about your health, pain experience, and related factors. The software is designed to communicate with you in a conversational manner, similar to talking with a healthcare provider, to gather information about your condition. You will be asked about various aspects of your chronic pain experience, including how it affects your daily life, your emotional state, and your social interactions. Who Can Participate: This study is looking for participants who have chronic pain conditions. Medical providers who treat patients with chronic pain are encouraged to refer eligible patients to this study. Healthcare providers interested in referring patients or learning more about the study can contact the study sponsor, AugMend Health Inc. Why This Research Matters: Chronic pain affects millions of people and understanding the full scope of how it impacts patients requires collecting detailed information about physical, psychological, and social factors. Traditional methods of collecting this information can be ti

Primary Outcome

Acceptability will be measured using the Acceptability, Feasibility and Usability Survey (AFUS) - Acceptability Subscale, a researcher-developed instrument. This subscale includes items from Part 1 (Core Assessment Experience), Part 2 (culture), Part 3 (Future Use \& Preference), Part 4 (Privacy \& Trust), and Part 5 (Medical Disclosure Comfort). Items are rated on a 7-point Likert scale (1 = Strongly Disagree to 7 = Strongly Agree). Subscale scores will be calculated as the mean of all acceptab

Interventions

  • OTHER Digital Biopsychosocial Conversational Data Collection Software
  • OTHER Standard Digital Questionnaire Data Collection

Study Locations (1)

Massachusetts

  • AugMend Health at MIT.nano Immersion Lab - Cambridge

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-10-03
Est. Completion 2026-07-31
Phase NA
AugMend Health

1 total trials

What NCT07336537 shows while recruiting

NCT07336537 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (87% lower).

The record links to 4 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Digital Biopsychosocial Conversational Data Collection Software is the first listed.

NCT07336537 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07336537 about?

NCT07336537 is a clinical study titled "Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software". This research study is being conducted to evaluate digital software tools that collect health information through conversations. The study will test how acceptable, feasible, and usable these conversational software programs are for patients with chronic pain. Purpose of the Study: The goal is to ...

What is the current status of trial NCT07336537?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-10-03. Estimated completion is 2026-07-31.

What conditions does trial NCT07336537 study?

This clinical trial studies the following conditions: Chronic Pain, Mental Health Disorders, Behavioral Health Challenges, Ecological Momentary Assessment Best Practices.

What interventions are being tested in trial NCT07336537?

The interventions under investigation include: Digital Biopsychosocial Conversational Data Collection Software (OTHER), Standard Digital Questionnaire Data Collection (OTHER).

Who is sponsoring clinical trial NCT07336537?

This trial is sponsored by AugMend Health, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07336537 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07336537's enrollment target sits among peer trials

100 132nd of 301 higher than 164 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07336537, the US trial registry maintained by the National Library of Medicine. NCT07336537 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.